CVS Health Corporation (CVS)

Over the past six months, CVS Health's stock price increased by 5.69% over the past 30 days and 23.16% over the past 12 months, with a price of $77.49 as of October 3, 2025. However, as of September 2025, the stock had fallen approximately 12% year-to-date. Key events include the completion of 900 store closures in December 2024, the implementation of the CostVantage reimbursement model in January 2025, and analysts highlighting the company's strategic positioning and digital health platforms as potential recovery catalysts.

CVS Health experiences demand seasonality, particularly in its Pharmacy & Consumer Wellness segment. The first quarter of 2025 saw growth driven by seasonal trends like high vaccine demand and a prolonged flu season. The flu season consistently increases foot traffic and ancillary sales, serving as a near-term catalyst for the company's performance.

CVS Health Corporation is a multinational healthcare company with a vertically integrated business model encompassing retail pharmacy, health insurance, and pharmacy benefit management. Its services are divided into three segments: Pharmacy & Consumer Wellness, which includes CVS Pharmacy and Omnicare; Health Care Benefits, provided through Aetna; and Health Services, focusing on pharmacy benefit management and healthcare services via medical clinics and virtual platforms.

CVS Health's operations are primarily in the United States, with its headquarters in Woonsocket, Rhode Island, and operational hubs in Irving, Texas; Chicago, Illinois; and Scottsdale, Arizona. While its retail and direct patient care are U.S.-centric, it has a global presence through supply chain management, international technology partnerships, and serving medical members outside the U.S. As of 2021, it had over 9,900 retail locations and nearly 1,200 walk-in medical clinics.

CVS Health has a strong brand reputation, recognized by FORTUNE magazine as one of the "World's Most Admired Companies" for five consecutive years, ranking No. 35 overall and No. 1 in the Health Care: Pharmacy and Other Services category as of January 2019. The company has also received acknowledgments from Forbes Most Valuable Brands and Corporate Responsibility Magazine's 100 Best Corporate Citizens. Prior to 2019, CVS Health focused on strengthening community health and addressing the opioid epidemic, and the acquisition of Aetna in November 2018 was a significant strategic move.

CVS Health Corporation's ownership is mainly institutional, with institutional investors holding approximately 76% to 83% of the shares. The top institutional shareholders include BlackRock, Inc., Vanguard Group Inc, Dodge & Cox, Capital World Investors, and State Street Corp. Vanguard Group, Inc. is the largest shareholder, holding 9.3% of outstanding shares as of April 2025. Retail investors hold around 17-24%, and insiders own less than 1%.